Publications by authors named "Claas Ulrich"

Claim this Profile
D
Does early discontinuation of topical 4% 5-fluorouracil affect lesion clearance for actinic keratosis? Results from a dose-ranging study.
Markus V Heppt, Claas Ulrich

J Eur Acad Dermatol Venereol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6.
Brett G M Hughes, Alexander Guminski, Samantha Bowyer, Michael R Migden, Chrysalyne D Schmults, Claas Ulrich

J Am Acad Dermatol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The "Personalising Actinic Keratosis Treatment for Immunocompromised Patients" (IM-PAKT) Project: An Expert Panel Opinion.
Rolf-Markus Szeimies, Claas Ulrich, Carla Ferrándiz-Pulido, Gunther F L Hofbauer, John Thomas Lear

Dermatol Ther (Heidelb)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dataset for: Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune-related adverse events.
Leonie Müller-Jensen, Samuel Knauss, Lorena Ginesta Roque, Christian Schinke, Smilla K Maierhof, Claas Ulrich

Data Brief· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune signatures of checkpoint inhibitor-induced autoimmunity-A focus on neurotoxicity.
Leonie Müller-Jensen, Axel R Schulz, Henrik E Mei, Raphael Mohr, Claas Ulrich

Neuro Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 open-label, multicenter, single-arm study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Extended follow-up.
Alexander J Stratigos, Aleksandar Sekulic, Ketty Peris, Oliver Bechter, Sorilla Prey, Claas Ulrich, Jens Ulrich

J Am Acad Dermatol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redefine photoprotection: Sun protection beyond sunburn.
Mirja van Bodegraven, Marius Kröger, Daniela F Zamudio Díaz, Silke B Lohan, Rose K C Moritz, Claas Ulrich

Exp Dermatol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma" - update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention.
Ulrike Leiter, Markus V Heppt, Theresa Steeb, Mareike Alter, Teresa Amaral, Claas Ulrich

J Dtsch Dermatol Ges· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[S3-Leitlinie "Aktinische Keratose und Plattenepithelkarzinom der Haut" - Update 2023, Teil 2: Epidemiologie und Ätiologie, Diagnostik, Therapie des invasiven Plattenepithelkarzinoms der Haut, Nachsorge und Prävention: S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma" - update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention].
Ulrike Leiter, Markus V Heppt, Theresa Steeb, Mareike Alter, Teresa Amaral, Claas Ulrich

J Dtsch Dermatol Ges· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[S3-Leitlinie "Aktinische Keratose und Plattenepithelkarzinom der Haut" - Update 2023, Teil 1: Therapie der aktinischen Keratose, Morbus Bowen, Cheilitis actinica, berufsbedingte Erkrankung und Versorgungsstrukturen: S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma"- update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care].
Markus V Heppt, Ulrike Leiter, Theresa Steeb, Mareike Alter, Teresa Amaral, Claas Ulrich

J Dtsch Dermatol Ges· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S3 guideline "actinic keratosis and cutaneous squamous cell carcinoma"- update 2023, part 1: treatment of actinic keratosis, actinic cheilitis, cutaneous squamous cell carcinoma in situ (Bowen's disease), occupational disease and structures of care.
Markus V Heppt, Ulrike Leiter, Theresa Steeb, Mareike Alter, Teresa Amaral, Claas Ulrich

J Dtsch Dermatol Ges· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoantibody profiles in patients with immune checkpoint inhibitor-induced neurological immune related adverse events.
Leonie Müller-Jensen, Samuel Knauss, Lorena Ginesta Roque, Christian Schinke, Smilla K Maierhof, Claas Ulrich

Front Immunol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of induced pluripotent stem cells from three individuals with Huntington's disease.
Duncan C Miller, Pawel Lisowski, Selene Lickfett, Barbara Mlody, Miriam Bünning, Claas Ulrich

Stem Cell Res· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker-driven therapies for metastatic uveal melanoma: A prospective precision oncology feasibility study.
Serge Leyvraz, Frank Konietschke, Caroline Peuker, Moritz Schütte, Thomas Kessler, Claas Ulrich, Ulrich Keilholz

Eur J Cancer· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Cell Proliferation and Cell Viability by Sinecatechins in Cutaneous SCC Cells Is Related to an Imbalance of ROS and Loss of Mitochondrial Membrane Potential.
Jiaqi Zhu, Bernd Gillissen, Dieu Linh Dang Tran, Stefanie May, Claas Ulrich

Antioxidants (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crucial Role of Reactive Oxygen Species (ROS) for the Proapoptotic Effects of Indirubin Derivatives in Cutaneous SCC Cells.
Jiaqi Zhu, Peter Langer, Claas Ulrich, Jürgen Eberle

Antioxidants (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New methods for assessing secondary performance attributes of sunscreens suitable for professional outdoor work.
Marc Rocholl, Patricia Weinert, Stephan Bielfeldt, Sabrina Laing, Klaus Peter Wilhelm, Claas Ulrich

J Occup Med Toxicol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial.
Alexander J Stratigos, Aleksandar Sekulic, Ketty Peris, Oliver Bechter, Sorilla Prey, Claas Ulrich, Jens Ulrich

Lancet Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High ROS Production by Celecoxib and Enhanced Sensitivity for Death Ligand-Induced Apoptosis in Cutaneous SCC Cell Lines.
Jiaqi Zhu, Stefanie May, Claas Ulrich, Eggert Stockfleth, Jürgen Eberle

Int J Mol Sci· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tape stripping the stratum corneum for biomarkers of ultraviolet radiation exposure at sub-erythemal dosages: a study in human volunteers.
Anne J Keurentjes, Ivone Jakasa, Swen M John, Claas Ulrich, Marcel W Bekkenk

Biomarkers· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing.
Danny Rischin, Michael R Migden, Annette M Lim, Chrysalyne D Schmults, Nikhil I Khushalani, Claas Ulrich

J Immunother Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) - short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow-up, prevention and occupational disease.
Ulrike Leiter, Markus V Heppt, Theresa Steeb, Teresa Amaral, Andrea Bauer, Claas Ulrich

J Dtsch Dermatol Ges· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Ulrike Leiter, Markus V Heppt, Theresa Steeb, Teresa Amaral, Andrea Bauer, Claas Ulrich

J Dtsch Dermatol Ges· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Markus V Heppt, Ulrike Leiter, Theresa Steeb, Teresa Amaral, Andrea Bauer, Claas Ulrich

J Dtsch Dermatol Ges· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma - short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality-of-care indicators.
Markus V Heppt, Ulrike Leiter, Theresa Steeb, Teresa Amaral, Andrea Bauer, Claas Ulrich

J Dtsch Dermatol Ges· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis